Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Sell
13
FMED Quote, Financials, Valuation and Earnings
Last price:
$25.02
Seasonality move
:
6.02%
Day range:
$24.66 - $25.19
52-week range:
$23.32 - $26.68
Dividend yield:
0.45%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6.3K
Avg. volume:
4.1K
1-year change:
9.68%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FMED
Fidelity Disruptive Medicine ETF
|
$25.03 | -- | -- | -- | $0.11 | 0.45% | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
$32.31 | -- | -- | -- | $0.18 | 0.55% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$29.15 | -- | -- | -- | $0.47 | 0.49% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.03 | -- | -- | -- | $0.00 | 0% | -- |
|
MEDI
Harbor Health Care ETF
|
$25.03 | -- | -- | -- | $0.13 | 0.54% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | 1.297 | -- | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | 1.154 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.605 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | 1.452 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- | -- |
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- | -- |
Fidelity Disruptive Medicine ETF vs. Competitors
-
Which has Higher Returns FMED or GDOC?
Goldman Sachs Future Health Care Equity ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat Goldman Sachs Future Health Care Equity ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FMEDFidelity Disruptive Medicine ETF-- -- -- GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -
What do Analysts Say About FMED or GDOC?
Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Goldman Sachs Future Health Care Equity ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than Goldman Sachs Future Health Care Equity ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than Goldman Sachs Future Health Care Equity ETF.
Company Buy Ratings Hold Ratings Sell Ratings FMEDFidelity Disruptive Medicine ETF0 0 0 GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 -
Is FMED or GDOC More Risky?
Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FMED or GDOC?
Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.45%. Goldman Sachs Future Health Care Equity ETF offers a yield of 0.55% to investors and pays a quarterly dividend of $0.18 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. Goldman Sachs Future Health Care Equity ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FMED or GDOC?
Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than Goldman Sachs Future Health Care Equity ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than Goldman Sachs Future Health Care Equity ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while Goldman Sachs Future Health Care Equity ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for Goldman Sachs Future Health Care Equity ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMEDFidelity Disruptive Medicine ETF-- -- -- -- GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- --
-
Which has Higher Returns FMED or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FMEDFidelity Disruptive Medicine ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About FMED or HRTS?
Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings FMEDFidelity Disruptive Medicine ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is FMED or HRTS More Risky?
Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FMED or HRTS?
Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.45%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.47 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FMED or HRTS?
Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMEDFidelity Disruptive Medicine ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns FMED or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FMEDFidelity Disruptive Medicine ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About FMED or HTEC?
Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings FMEDFidelity Disruptive Medicine ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is FMED or HTEC More Risky?
Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.985%.
-
Which is a Better Dividend Stock FMED or HTEC?
Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.45%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FMED or HTEC?
Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMEDFidelity Disruptive Medicine ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns FMED or MEDI?
Harbor Health Care ETF has a net margin of -- compared to Fidelity Disruptive Medicine ETF's net margin of --. Fidelity Disruptive Medicine ETF's return on equity of -- beat Harbor Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FMEDFidelity Disruptive Medicine ETF-- -- -- MEDIHarbor Health Care ETF-- -- -- -
What do Analysts Say About FMED or MEDI?
Fidelity Disruptive Medicine ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Harbor Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity Disruptive Medicine ETF has higher upside potential than Harbor Health Care ETF, analysts believe Fidelity Disruptive Medicine ETF is more attractive than Harbor Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings FMEDFidelity Disruptive Medicine ETF0 0 0 MEDIHarbor Health Care ETF0 0 0 -
Is FMED or MEDI More Risky?
Fidelity Disruptive Medicine ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Harbor Health Care ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FMED or MEDI?
Fidelity Disruptive Medicine ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.45%. Harbor Health Care ETF offers a yield of 0.54% to investors and pays a quarterly dividend of $0.13 per share. Fidelity Disruptive Medicine ETF pays -- of its earnings as a dividend. Harbor Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FMED or MEDI?
Fidelity Disruptive Medicine ETF quarterly revenues are --, which are smaller than Harbor Health Care ETF quarterly revenues of --. Fidelity Disruptive Medicine ETF's net income of -- is lower than Harbor Health Care ETF's net income of --. Notably, Fidelity Disruptive Medicine ETF's price-to-earnings ratio is -- while Harbor Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity Disruptive Medicine ETF is -- versus -- for Harbor Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FMEDFidelity Disruptive Medicine ETF-- -- -- -- MEDIHarbor Health Care ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.65% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.9% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.4% over the past day.
